Maroda László

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2018-2024

2024

Kovács, B., Németh, Á., Daróczy, B., Karányi, Z., Maroda, L., Diószegi, Á., Páll, D., Harangi, M.: A lipidanyagcsere eltéréseinek vizsgálata felnőtt hypertoniás betegek esetén adatbányászati módszerrel.
Hyperton. nephrol. 28 (1), 13-18, 2024.

doi DEA

2023

Kovács, B., Németh, Á., Daróczy, B., Karányi, Z., Maroda, L., Diószegi, Á., Harangi, M., Páll, D.: Assessment of Hypertensive Patients' Complex Metabolic Status Using Data Mining Methods.
J. Cardiovasc. Dev. Dis. 10 (8), 1-14, (article identifier: 345), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Q2 Pharmacology (medical)

Kovács, B., Németh, Á., Daróczy, B., Karányi, Z., Maroda, L., Diószegi, Á., Nádró, B., Szabó, T., Harangi, M., Páll, D.: Determining the prevalence of childhood hypertension and its concomitant metabolic abnormalities using data mining methods in the Northeastern region of Hungary.
Front. Cardiovasc. Med. 9, 1-10, (article identifier: 1081986), 2023.

doi DEA WoS Scopus

Journal metrics:

Q2 Cardiology and Cardiovascular Medicine

2022

Köbling, T., Maroda, L., Katona, É., Váradi, Z., Somodi, S., Páll, D., Zrínyi, M.: Discriminating low to high adherent type 2 patients with diabetes by glycosylated hemoglobin A1c, eating self-efficacy and other psychosocial determinants: difference between patient and physician adherence models.
Patient Prefer. Adher. 16, 1405-1414, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Health Policy

Q2 Medicine (miscellaneous)

Q1 Social Sciences (miscellaneous)

Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Kovács, B., Cseprekál, O., Diószegi, Á., Lengyel, S., Maroda, L., Paragh, G., Harangi, M., Páll, D.: The Importance of Arterial Stiffness Assessment in Patients with Familial Hypercholesterolemia.
J Clin Med. 11 (10), 1-14, (article identifier: 2872), 2022.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

2018

Páll, D., Maroda, L., Zrínyi, M.: A [béta]-blokkolók helye a hypertonia kezelésében, különös tekintettel a carvedilolra.
Hyperton. Nephrol. 22 (2), 89-93, 2018.

DEA